While cMyBP-C is predominantly cardiac-specific, its specificity can be influenced by conditions like chronic kidney disease or a history of heart failure, where elevated baseline levels have been reported in previous studies due to ongoing cardiomyocyte stress or reduced clearance. This evidence concerns the gene MYBPC3 and heart failure.